Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23635728 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)
Condition: Uterine Hemorrhage
Interventions: Drug: Tranexamic acid;   Drug: Mefenamic acid;   Drug: Placebo;   Drug: Mirena (Levonorgestrel IUS, BAY86-5028)

Indicates status has not been verified in more than two years